Business Context and Reporting Period
This Form 8-K is a current report filed by Enochian Biosciences Inc. (not Lunai Bioworks Inc.) on July 11, 2023, regarding an event that occurred on July 7, 2023. The company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market under the symbol ENOB.
Key Financial Metrics
This filing is a notice of a listing deficiency and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
The material event reported is the receipt of a deficiency notice from Nasdaq. The company's common stock failed to comply with the $1.00 minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)) based on the closing bid price over the 30 consecutive business days prior to the notice. There is no immediate effect on the listing status, and trading continues under the symbol ENOB.
Guidance, Outlook, and Risks
- Compliance Timeline: The company has an initial compliance period of 180 calendar days, ending on January 3, 2024.
- Remediation Requirement: To regain compliance, the closing bid price must meet or exceed $1.00 per share for a minimum of ten consecutive business days prior to the deadline.
- Future Risks: If compliance is not met by January 3, 2024, the company may be eligible for a second 180-day period if it meets other listing standards (e.g., market value of publicly held shares). Failure to qualify for or succeed in the second period could result in delisting.
- Management Action: Management intends to monitor the stock price and is considering options to regain compliance.
Investor Verification Checklist
- Verify the current trading price of ENOB to assess the gap from the $1.00 threshold.
- Monitor the company's stock price daily to track progress toward the 10-day consecutive compliance requirement.
- Review upcoming filings for any announcements regarding reverse stock splits or other corporate actions intended to address the bid price deficiency.
- Check the company's market capitalization and public float to determine eligibility for a second compliance period if the first deadline is missed.